Nalaganje...

BCR: a promiscuous fusion partner in hematopoietic disorders

Considerable advances have been made in our understanding of the molecular basis of hematopoietic cancers. The discovery of the BCR-ABL fusion protein over 50 years ago has brought about a new era of therapeutic progress and overall improvement in patient care, mainly due to the development and use...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Peiris, Malalage N., Li, Fangda, Donoghue, Daniel J.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505627/
https://ncbi.nlm.nih.gov/pubmed/31105873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26837
Oznake: Označite
Brez oznak, prvi označite!